Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM

避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染

基本信息

  • 批准号:
    10399433
  • 负责人:
  • 金额:
    $ 75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Abstract Young (aged 18-29) Black men who have sex with men (YBMSM) in Atlanta experience high rates of HIV acquisition (8.9%/year) and STI infection (30%/year). Over the past 5 years, we have followed a cohort of 300 YBMSM in Atlanta and have offered PrEP as part of a comprehensive package of prevention interventions. We have had substantial uptake of PrEP – over 40% of YBMSM initiated PrEP – but we have also observed high rates of PrEP discontinuation (39% of all PrEP starts) and ongoing high rates of new STI diagnoses. Even with 44% PrEP uptake in the cohort, HIV incidence remained high at 6.2%/year. This represents a 30% reduction in HIV incidence compared to our pre-PrEP comparison cohort, but is still unacceptably high. Therefore, we proposed to continue our cohort approach but to add three new interventions: (1) an innovative “early warning” system to identify YBMSM on PrEP who are at risk for discontinuing PrEP, and providing a motivational interviewing-based peer intervention; (2) offering on-demand PrEP to men who decline daily PrEP or who plan to stop daily PrEP because they are unwilling to take a daily pill or perceive their risks to be infrequent; and (3) offering STI PEP with doxycycline for all men, regardless of PrEP use, to avert new STIs. This is an implementation-focused, single arm cohort approach, using a target trial design to emulate a randomized trial and evaluation of process measures. Primary outcomes are rates of PrEP discontinuation and rates of new STI diagnoses.
摘要 亚特兰大的年轻(18-29岁)黑人男男性行为者(YBMSM)感染艾滋病毒的比率很高 感染率(8.9%/年)和性传播感染率(30%/年)。在过去的5年里,我们跟踪了300名 YBMSM在亚特兰大,并提供了PrEP作为一个全面的一揽子预防干预措施的一部分。 我们已经大量吸收了PrEP -超过40%的YBMSM启动了PrEP -但我们也观察到 PrEP中断率高(所有PrEP开始的39%)和新的STI诊断率持续高。 即使队列中PrEP摄取率为44%,艾滋病毒发病率仍高达6.2%/年。这代表了30% 与我们的PrEP前比较队列相比,HIV发病率有所降低,但仍然高得不可接受。 因此,我们建议继续我们的队列方法,但增加三个新的干预措施:(1)创新的 “早期预警”系统,以确定YBMSM在PrEP谁是在风险中断PrEP,并提供一个 基于动机访谈的同伴干预;(2)向拒绝每日PrEP的男性提供按需PrEP 或计划停止每日PrEP的人,因为他们不愿意每天服用药丸或认为他们的风险是 罕见;(3)为所有男性提供带有强力霉素的STI PEP,无论是否使用PrEP,以避免新的STI。 这是一种以实施为重点的单臂队列方法,使用靶向试验设计来模拟 随机试验和过程措施评价。主要结局是PrEP中止率 和新的性传播感染诊断率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Colleen F Kelley其他文献

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial
PGDM1400LS 是一种 V2 特异性 HIV-1 广泛中和抗体,在美国无 HIV-1 人群中静脉或皮下输注的安全性、药代动力学和中和活性(HVTN 140/HPTN 101 A 部分):一项首次人体、1 期随机试验
  • DOI:
    10.1016/s2352-3018(25)00012-8
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    13.000
  • 作者:
    Kelly E Seaton;Carmen A Paez;Chenchen Yu;Shelly T Karuna;Theresa Gamble;Maurine D Miner;Jack Heptinstall;Lu Zhang;Fei Gao;Margaret Yacovone;Hans Spiegel;Julie B Dumond;Maija Anderson;Estelle Piwowar-Manning;Bonnie Dye;India Tindale;Lori Proulx-Burns;Meg Trahey;Simbarashe Takuva;Azwidihwi Takalani;Colleen F Kelley
  • 通讯作者:
    Colleen F Kelley
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
开发用于评估体内结核病免疫力的人类卡介苗挑战模型的第一阶段开放标签剂量递增试验。
  • DOI:
    10.1093/infdis/jiad441
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Azra Blazevic;Rachel L Edwards;Mei Xia;C. Eickhoff;Fahreta Hamzabegovic;Krystal A. Meza;Huan Ning;Jan Tennant;Karla J Mosby;James C Ritchie;Tigisty Girmay;Lilin Lai;Michele McCullough;Allison Beck;Colleen F Kelley;Srilatha Edupuganti;Sarah Kabbani;Wendy Buchanan;M. Makhene;Delia Voronca;Sami R. Cherikh;Johannes B. Goll;N. Rouphael;Mark J. Mulligan;D. Hoft
  • 通讯作者:
    D. Hoft

Colleen F Kelley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Colleen F Kelley', 18)}}的其他基金

Defining Sex-Specific Systemic and Gut Inflammatory Profiles in People Living with HIV
定义艾滋病毒感染者的性别特异性全身和肠道炎症特征
  • 批准号:
    10619980
  • 财政年份:
    2023
  • 资助金额:
    $ 75万
  • 项目类别:
Gender as a biological variable: transcriptomic analysis of rectal mucosal immune cells among transgender people
性别作为生物变量:变性人直肠粘膜免疫细胞的转录组分析
  • 批准号:
    10376886
  • 财政年份:
    2021
  • 资助金额:
    $ 75万
  • 项目类别:
Gender as a biological variable: transcriptomic analysis of rectal mucosal immune cells among transgender people
性别作为生物变量:变性人直肠粘膜免疫细胞的转录组分析
  • 批准号:
    10258036
  • 财政年份:
    2021
  • 资助金额:
    $ 75万
  • 项目类别:
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM
避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染
  • 批准号:
    9927385
  • 财政年份:
    2020
  • 资助金额:
    $ 75万
  • 项目类别:
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM
避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染
  • 批准号:
    10133150
  • 财政年份:
    2020
  • 资助金额:
    $ 75万
  • 项目类别:
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM
避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染
  • 批准号:
    10652666
  • 财政年份:
    2020
  • 资助金额:
    $ 75万
  • 项目类别:
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
了解跨性别激素治疗对美国和泰国变性女性直肠粘膜的影响
  • 批准号:
    10672350
  • 财政年份:
    2019
  • 资助金额:
    $ 75万
  • 项目类别:
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
了解跨性别激素治疗对美国和泰国变性女性直肠粘膜的影响
  • 批准号:
    10227723
  • 财政年份:
    2019
  • 资助金额:
    $ 75万
  • 项目类别:
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
了解跨性别激素治疗对美国和泰国变性女性直肠粘膜的影响
  • 批准号:
    10447095
  • 财政年份:
    2019
  • 资助金额:
    $ 75万
  • 项目类别:
STI and Implications for HIV Transmission and Prevention
性传播感染以及对艾滋病毒传播和预防的影响
  • 批准号:
    9334534
  • 财政年份:
    2017
  • 资助金额:
    $ 75万
  • 项目类别:

相似海外基金

Distinct ethnic, clinical, and genetic characteristics of der(1;7) in myelodysplastic syndromes
骨髓增生异常综合征中 der(1;7) 的独特种族、临床和遗传特征
  • 批准号:
    22KJ1756
  • 财政年份:
    2023
  • 资助金额:
    $ 75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Correlating the microstructural thickness variations of the tear film lipid layer with clinical characteristics of dry eye with a novel optical method
用一种新颖的光学方法将泪膜脂质层的微观结构厚度变化与干眼的临床特征相关联
  • 批准号:
    10636304
  • 财政年份:
    2023
  • 资助金额:
    $ 75万
  • 项目类别:
Characteristics, predictors of deterioration, and clinical outcomes in children with hospital-onset sepsis
院内败血症儿童的特征、恶化预测因素和临床结果
  • 批准号:
    486582
  • 财政年份:
    2022
  • 资助金额:
    $ 75万
  • 项目类别:
    Studentship Programs
Clinical characteristics and prognosis of patients with myocardial infarction with non-obstructive coronary artery in Japan
日本非梗阻性冠状动脉心肌梗死患者的临床特征及预后
  • 批准号:
    22K08147
  • 财政年份:
    2022
  • 资助金额:
    $ 75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of Neighborhood Characteristics on Conversion to Psychosis among Youth at Clinical High Risk for Psychosis
社区特征对临床精神病高危青少年转化为精神病的影响
  • 批准号:
    10429549
  • 财政年份:
    2022
  • 资助金额:
    $ 75万
  • 项目类别:
Impact of Neighborhood Characteristics on Conversion to Psychosis among Youth at Clinical High Risk for Psychosis
社区特征对临床精神病高危青少年转化为精神病的影响
  • 批准号:
    10650851
  • 财政年份:
    2022
  • 资助金额:
    $ 75万
  • 项目类别:
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
区分抗磷脂酰乙醇胺两种亚型的临床特征
  • 批准号:
    10654055
  • 财政年份:
    2022
  • 资助金额:
    $ 75万
  • 项目类别:
Predicting long-term clinical outcomes by optical coherence tomography assessment of plaque characteristics in the non-revascularized coronary artery
通过光学相干断层扫描评估未血运重建冠状动脉中的斑块特征来预测长期临床结果
  • 批准号:
    22K08202
  • 财政年份:
    2022
  • 资助金额:
    $ 75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
区分抗磷脂酰乙醇胺两种亚型的临床特征
  • 批准号:
    10510394
  • 财政年份:
    2022
  • 资助金额:
    $ 75万
  • 项目类别:
Comprehensive analysis of pathologic, genomic, and clinical characteristics in RhoGAP gastric cancer
RhoGAP胃癌病理、基因组和临床特征的综合分析
  • 批准号:
    21K06918
  • 财政年份:
    2021
  • 资助金额:
    $ 75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了